Eisai
4523.T
#1991
Rank
C$11.58 B
Marketcap
$41.09
Share price
-1.79%
Change (1 day)
-28.71%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.14. In 2022 the company made an earnings per share (EPS) of $2.30 a decrease over its 2021 EPS that were of $10.23.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9527.99%
2022$2.30-77.48%
2021$10.23-41.88%
2020$17.59-0.94%
2019$17.7652.59%
2018$11.64124.17%
2017$5.19-49.42%
2016$10.2737.08%
2015$7.49-11.75%
2014$8.49-3.23%
2013$8.77-18.56%
2012$10.77-15.51%
2011$12.75-3.75%
2010$13.24-1.36%
2009$13.43